An iron chelator used for the treatment of acute iron intoxication and of chronic iron overload due to transfusion-dependent anemias. Has been shown to have anti-proliferative effects on vascular smooth muscle cells in vitro and in vivo and to arrest cells in the G1 phase. Induces apoptosis in HL-60 cells by chelating iron. In addition, it has been shown to have antioxidant properties and to protect cells against H?O?-induced damage. MW: 656.79. Purity ≥98% by HPLC
Size
500 mg
Concentration
n/a
Applications
n/a
Other Names
DFOM, Deferoxamine methanesulfonate salt, Desferrioxamine mesylate salt